KRAS and non-small cell lung carcinoma: While the relationship between FDG uptake and EGFR mutations in NSCLC has previously been noted to have contradictory results [15, 16], and one notable study has shown that the KRAS mutations in lung cancer showed significantly higher FDG uptake than wild type (WT) cancer [17].